首页 > 市场调查报告书 > 医疗设备

病患监测血糖监测

市场调查报告书

商品编码

1624431

2024 年至 2031 年血糖仪市场（依产品、技术、通路和地区划分）

Glucometer Market By Product (Continuous Glucose Monitoring Devices, Self-Monitoring Blood Glucose (SMBG) Systems), Technique (Invasive, Non-invasive), Distribution Channel (Hospital, Retail, Online), And Region for 2024-2031

出版日期: 2024年11月18日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024 年至 2031 年血糖机市场评估

透过补贴、保险覆盖和公共卫生计划增加获得糖尿病护理和管理设备（如血糖仪）的机会是市场扩张的主要驱动力。据 Verified Market Research 分析师称，血糖仪市场规模预计将从 2024 年的约 106.8 亿美元下降到 2031 年预测期内的 243.8 亿美元。

由于人口老化、久坐的生活方式和肥胖率上升等因素，全球糖尿病患者数量不断增加，大大推动了对血糖测量设备的需求。这将使市场从 2024 年到 2031 年的复合年增长率达到 10.87%。

血糖仪市场定义/概述

血糖仪，也称为血糖仪，是一种用于测量和监测血液中葡萄糖浓度的便携式医疗设备。血糖监测仪主要由糖尿病患者使用，在管理血糖水平方面发挥至关重要的作用，这对于有效控製糖尿病至关重要。该设备通常由一个带有数位显示器的小型手持装置和一个用于刺穿皮肤获取血液样本的刺血针组成。使用者将一滴血液放在一次性试纸上，然后将其插入血糖仪中。

血糖仪分析血液样本并显示血糖值的数值读数，通常以毫克每分升 (mg/dL) 或毫摩尔每公升 (mmol/L) 表示。定期使用血糖仪监测可以对饮食、药物和生活方式做出明智的决定，最终有助于维持最佳血糖控制并预防糖尿病相关併发症，有助于降低疾病风险。

糖尿病盛行率的上升将如何影响血糖仪市场的成长？

糖尿病盛行率的不断上升将对有效血糖监测解决方案的需求产生更大的影响，从而显着影响血糖仪市场的成长。根据国际糖尿病联盟的数据，2021年将有约5.37亿成年人罹患糖尿病，预计2030年这一数字将增加至6.43亿，到2045年将增加至7.83亿。糖尿病患者数量的增加凸显了对血糖仪的迫切需求，因为定期监测对于控制血糖水平和预防糖尿病相关併发症至关重要。

此外，政府措施支持的糖尿病管理意识不断增强以及自我监测实践的重要性进一步推动了市场需求。光是 2021 年，糖尿病就将导致全球约 670 万人死亡，凸显了对可用监测工具的迫切需求。

此外，持续血糖监测系统的发展等技术进步使得这些设备更加用户友好、更具吸引力，进一步促进了市场的扩大。

血糖机市场製造商面临的主要技术课题是什么？

血糖仪市场的製造商面临着多项技术课题，这些课题影响了他们跟上创新和不断增长的消费者需求的能力。主要课题之一是需要提高血糖测量的准确性和可靠性。儘管取得了进步，但血糖仪读数和实际血糖水平之间仍可能存在差异，这可能导致糖尿病管理不善。根据国际糖尿病联盟的数据，糖尿病将导致 2021 年约 670 万人死亡，凸显了对精准监测工具的迫切需求，以防止此类后果。

此外，法规遵循是一个主要障碍。血糖仪被归类为医疗设备，因此必须遵守美国食品药物管理局 (FDA) 等机构制定的严格规定。这个合规过程既耗时又昂贵，常常会延迟产品发布和创新。另一个课题是来自替代监测方法的竞争，例如持续血糖监测 (CGM) 系统，它可以提供即时数据而无需频繁刺穿手指。随着CGM技术越来越普及，传统血糖仪製造商必须投入研发来增强其产品并维持市场占有率。

此外，先进的血糖仪技术价格昂贵，这可能会限制其可及性，特别是在糖尿病盛行率不断上升的中低收入国家。这些综合的技术课题意味着，为了有效管理糖尿病，製造商必须在适应监管环境和应对市场竞争的同时不断创新。

Enhance access to diabetes care and management instruments, such as glucometers, via subsidies, insurance coverage, and public health programmes, are critical drivers of market expansion. According to the analyst from Verified Market Research, the Glucometer Market is estimated to reach a valuation of USD 24.38 Billion over the forecast period 2031, by subjugating around USD 10.68 Billion valued in 2024.

The global increase in diabetes cases, caused by factors such as ageing populations, sedentary lifestyles, and rising obesity rates, is significantly driving up demand for glucometers. It enables the market to grow at a CAGR of 10.87% from 2024 to 2031.

Glucometer Market: Definition/ Overview

A glucometer, also known as a blood glucose meter, is a portable medical device designed to measure and monitor the concentration of glucose in a person's blood. Primarily used by individuals with diabetes, glucometers play a crucial role in managing blood glucose levels, which is essential for effective diabetes control. The device typically consists of a small handheld unit with a digital display, along with a lancet for pricking the skin to obtain a blood sample. Users place a drop of blood on a disposable test strip, which is then inserted into the glucometer.

Glucometer analyzes the blood sample and provides a numerical reading of the blood glucose level, usually expressed in milligrams per deciliter (mg/dL) or millimoles per liter (mmol/L). Regular monitoring with a glucometer enables individuals to make informed decisions about their diet, medication, and lifestyle, ultimately helping to maintain optimal blood sugar control and reduce the risk of diabetes-related complications.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How does the Increasing Prevalence of Diabetes Influence the Growth of the Glucometer Market?

The increasing prevalence of diabetes significantly influences the growth of the glucometer market by creating a larger demand for effective blood glucose monitoring solutions. According to the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2021, a figure projected to rise to 643 million by 2030 and further to 783 million by 2045. This escalating number of diabetes cases highlights the urgent need for glucometers, as regular monitoring is crucial for managing blood sugar levels and preventing complications associated with the disease.

Moreover, the growing awareness of diabetes management and the importance of self-monitoring practices, supported by government initiatives, further drive market demand. In 2021 alone, diabetes was responsible for approximately 6.7 million deaths worldwide, emphasizing the critical need for accessible monitoring tools.

Additionally, advancements in technology, such as the development of continuous glucose monitoring systems, are making these devices more user-friendly and appealing, further contributing to market expansion.

What are the Main Technological Challenges Faced by Manufacturers in the Glucometer Market?

Manufacturers in the glucometer market face several technological challenges that impact their ability to innovate and meet growing consumer demands. One of the primary challenges is the need for enhanced accuracy and reliability in glucose measurements. Despite advancements, discrepancies between glucometer readings and actual blood glucose levels can occur, leading to potential mismanagement of diabetes. According to the International Diabetes Federation, diabetes resulted in approximately 6.7 million deaths in 2021, underscoring the critical need for precise monitoring tools to prevent such outcomes.

Additionally, regulatory compliance poses a significant hurdle. Glucometers are classified as medical devices, which means they must adhere to stringent regulations set forth by authorities like the U.S. Food and Drug Administration (FDA). This compliance process can be time-consuming and costly, often delaying product launches and innovations. Another challenge is the competition from alternative monitoring methods, such as continuous glucose monitoring (CGM) systems, which provide real-time data without the need for frequent finger pricking. As CGM technology gains popularity, traditional glucometer manufacturers must invest in research and development to enhance their offerings and retain market share.

Furthermore, the high cost of advanced glucometer technologies can limit accessibility, particularly in low- and middle-income countries where diabetes prevalence is rising. The combination of these technological challenges requires manufacturers to continuously innovate while navigating regulatory landscapes and addressing market competition to ensure the effective management of diabetes.

Category-Wise Acumens

What Factors Contribute to the Dominance of Self-monitoring Blood Glucose (SMBG) Systems in the Glucometer Market?

The dominance of self-monitoring blood glucose (SMBG) systems in the glucometer market can be attributed to several key factors. Firstly, the rising prevalence of diabetes significantly drives demand for these devices. According to the Centers for Disease Control and Prevention (CDC), approximately 11.6% of the U.S. population, equating to about 38.4 million individuals, were affected by diabetes in 2021. This growing patient base necessitates effective monitoring solutions to manage blood glucose levels effectively and prevent complications associated with the disease.

Additionally, advancements in technology have made SMBG systems more accurate, user-friendly, and accessible. Features such as Bluetooth connectivity, integration with mobile health applications, and improved test strip designs enhance the overall user experience, encouraging more individuals to engage in regular monitoring. Furthermore, supportive government initiatives and reimbursement policies for SMBG devices in many regions promote their adoption, making them more financially accessible to patients.

The shift towards home-based healthcare, accelerated by the COVID-19 pandemic, has also bolstered the SMBG market, as patients increasingly prefer the convenience of monitoring their blood glucose levels at home rather than frequent hospital visits.

How does the Cost-Effectiveness of Invasive Glucometers Contribute to their Market Dominance?

The cost-effectiveness of invasive glucometers significantly contributes to their dominance in the glucometer market by making them accessible to a broader range of consumers, particularly those managing diabetes. Invasive glucometers, which typically involve finger-pricking to obtain blood samples, are regarded as the gold standard for blood glucose monitoring due to their accuracy and reliability. The American Diabetes Association and the International Diabetes Federation recommend these devices for effective diabetes management, reinforcing their credibility among healthcare providers and patients alike.

Government statistics further highlight the importance of cost-effectiveness in this market. For instance, the Centers for Disease Control and Prevention (CDC) reported that approximately 11.6% of the U.S. population, or about 38.4 million individuals, were living with diabetes in 2021. As the demand for affordable and reliable monitoring solutions rises, invasive glucometers remain a preferred choice due to their relatively low initial costs compared to newer technologies like continuous glucose monitoring systems.

Moreover, the widespread availability of test strips and lancets, which are essential consumables for invasive glucometers, helps maintain their affordability. The combination of these factors ensures that invasive glucometers continue to dominate the market, as they provide a cost-effective solution for millions of individuals needing regular blood glucose monitoring to manage their diabetes effectively.

Country/Region-wise Acumens

What Factors are Driving Asia Pacific's Dominance in the Glucometer Market?

Asia Pacific's dominance in the glucometer market is driven by several key factors, primarily the rising prevalence of diabetes and increasing healthcare investments. The International Diabetes Federation reported that over 206 million adults in the Asia Pacific region were living with diabetes in 2021, a number projected to rise to 238 million by 2030. This alarming trend necessitates effective blood glucose monitoring solutions, leading to heightened demand for glucometers.

Additionally, the region has seen significant government initiatives aimed at improving diabetes management and healthcare infrastructure. Furthermore, increasing awareness about diabetes and its management among patients and healthcare providers is driving the adoption of self-monitoring blood glucose devices. The accessibility of advanced technologies, such as continuous glucose monitoring systems, is also enhancing the market landscape. Collectively, these factors position Asia Pacific as a rapidly expanding market for glucometers, with a strong outlook for continued growth in the coming years.

What Factors are Driving the Continuous Growth of the Glucometer Market in North America?

The glucometer market in North America is experiencing continuous growth driven by several key factors. One of the primary drivers is the increasing prevalence of diabetes in the region. According to the Centers for Disease Control and Prevention (CDC), approximately 37.3 million people in the United States had diabetes in 2021, representing 11.3% of the population. This alarming statistic highlights the urgent need for effective blood glucose monitoring solutions, which is fueling the demand for glucometers.

Technological advancements in glucometer design and functionality are also driving the market's expansion. The development of compact, user-friendly devices with improved accuracy and connectivity features, such as Bluetooth integration and mobile app integration, is making glucometers more appealing to patients and healthcare providers alike. These innovations are enhancing the overall user experience and encouraging more individuals to engage in regular blood glucose monitoring.

Furthermore, the growing awareness of the importance of diabetes management and the availability of educational resources are contributing to the market's growth. As patients and healthcare providers become more informed about the significance of regular blood glucose monitoring in preventing complications and improving overall health outcomes, the demand for glucometers is expected to continue rising.

Competitive Landscape

The Glucometer Market is characterized by fierce competition among participants, which is driven by technological advancements, accuracy, and user-friendliness. Other essential variables that organizations consider while establishing and maintaining their market presence include price competitiveness, product differentiation, and worldwide expansion.

Some of the prominent players operating in the glucometer market include:

Abbott Diabetes Care

Roche Diagnostics

Medtronic

Dexcom

LifeScan

Ascensia Diabetes Care

Ypsomed

Braun

Nipro

Sanofi

Arkray

Prodigy Diabetes Care

Acon Laboratories

Nova Biomedical

Terumo

Latest Developments

In October 2023, Abbott launched the FreeStyle Libre 3 system in Canada, which is designed to provide real-time glucose readings with a smaller, more discreet sensor that offers improved accuracy and comfort for users.

In September 2023, Roche launched the Accu-Chek Instant, a new glucometer designed to provide users with instant feedback on their blood glucose levels. This device features a user-friendly interface and offers advanced connectivity options, allowing users to track their glucose levels more efficiently through a mobile app.

1 INTRODUCTION OF GLOBAL GLUCOMETER MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL GLUCOMETER MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL GLUCOMETER MARKET, BY PRODUCT

5.1 Overview
5.2 Continuous Glucose Monitoring Devices
5.3 Self-Monitoring Blood Glucose (SMBG) Systems

6 GLOBAL GLUCOMETER MARKET, BY TECHNIQUE

6.1 Overview
6.2 Invasive
6.3 Non-invasive

7 GLOBAL GLUCOMETER MARKET, BY DISTRIBUTION CHANNEL

7.1 Overview
7.2 Hospital Pharmacies
7.3 Retail Pharmacies
7.4 Online Pharmacies
7.5 Others

8 GLOBAL GLUCOMETER MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL GLUCOMETER MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES

10.1 Abbott Diabetes Care
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Roche Diagnostics
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Medtronic
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Dexcom
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 LifeScan
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Ascensia Diabetes Care
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Ypsomed
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 B. Braun
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Nipro
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Sanofi
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments